184 related articles for article (PubMed ID: 20602173)
1. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.
Molica P; Nascif SO; Correa-Silva SR; de Sá LB; Vieira JG; Lengyel AM
Pituitary; 2010 Dec; 13(4):315-23. PubMed ID: 20602173
[TBL] [Abstract][Full Text] [Related]
2. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Correa-Silva SR; Nascif SO; Lengyel AM
Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
[TBL] [Abstract][Full Text] [Related]
3. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
[TBL] [Abstract][Full Text] [Related]
5. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
6. Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Nascif SO; Correa-Silva SR; Silva MR; Lengyel AM
Pituitary; 2007; 10(1):27-33. PubMed ID: 17410412
[TBL] [Abstract][Full Text] [Related]
7. Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease.
Correa-Silva SR; Nascif SO; Silva MR; Molica P; Lengyel AM
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1110-7. PubMed ID: 18157387
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs.
Bhatti SF; Duchateau L; Van Ham LM; De Vliegher SP; Mol JA; Rijnberk A; Kooistra HS
Vet J; 2006 Nov; 172(3):515-25. PubMed ID: 15951209
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis.
Nascif SO; Molica P; Correa-Silva SR; Silva MR; Lengyel AM
Pituitary; 2009; 12(4):315-21. PubMed ID: 19396632
[TBL] [Abstract][Full Text] [Related]
10. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
11. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
[TBL] [Abstract][Full Text] [Related]
12. Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH.
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Eur J Endocrinol; 2009 Nov; 161(5):681-6. PubMed ID: 19696160
[TBL] [Abstract][Full Text] [Related]
13. Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Nascif SO; Senger MH; Ramos-Dias JC; Lengyel AM
J Endocrinol Invest; 2003 Aug; 26(8):733-7. PubMed ID: 14669827
[TBL] [Abstract][Full Text] [Related]
14. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism.
Ramos-Dias JC; Pimentel-Filho F; Reis AF; Lengyel AM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1343-6. PubMed ID: 8636330
[TBL] [Abstract][Full Text] [Related]
15. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
Borges MH; DiNinno FB; Lengyel AM
Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702
[TBL] [Abstract][Full Text] [Related]
16. Ipamorelin, the first selective growth hormone secretagogue.
Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH
Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
19. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
20. GH responses to GHRH and GHRP-6 in Streptozotocin (STZ)-diabetic rats.
Diz Chaves Y; Spuch Calvar C; Pérez Tilve D; Mallo Ferrer F
Life Sci; 2003 Nov; 73(26):3375-85. PubMed ID: 14572879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
